417 related articles for article (PubMed ID: 31048895)
1. TRPV4 inhibition prevents increased water diffusion and blood-retina barrier breakdown in the retina of streptozotocin-induced diabetic mice.
Orduña Ríos M; Noguez Imm R; Hernández Godínez NM; Bautista Cortes AM; López Escalante DD; Liedtke W; Martínez Torres A; Concha L; Thébault S
PLoS One; 2019; 14(5):e0212158. PubMed ID: 31048895
[TBL] [Abstract][Full Text] [Related]
2. Dual contribution of TRPV4 antagonism in the regulatory effect of vasoinhibins on blood-retinal barrier permeability: diabetic milieu makes a difference.
Arredondo Zamarripa D; Noguez Imm R; Bautista Cortés AM; Vázquez Ruíz O; Bernardini M; Fiorio Pla A; Gkika D; Prevarskaya N; López-Casillas F; Liedtke W; Clapp C; Thébault S
Sci Rep; 2017 Oct; 7(1):13094. PubMed ID: 29026201
[TBL] [Abstract][Full Text] [Related]
3. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
4. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
Zhang J; Wu Y; Jin Y; Ji F; Sinclair SH; Luo Y; Xu G; Lu L; Dai W; Yanoff M; Li W; Xu GT
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):732-42. PubMed ID: 18235022
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomics analysis of pericytes from retinas of diabetic animals reveals novel genes and molecular pathways relevant to blood-retinal barrier alterations in diabetic retinopathy.
Rangasamy S; Monickaraj F; Legendre C; Cabrera AP; Llaci L; Bilagody C; McGuire P; Das A
Exp Eye Res; 2020 Jun; 195():108043. PubMed ID: 32376470
[TBL] [Abstract][Full Text] [Related]
8. Modulation of p75(NTR) prevents diabetes- and proNGF-induced retinal inflammation and blood-retina barrier breakdown in mice and rats.
Mysona BA; Al-Gayyar MM; Matragoon S; Abdelsaid MA; El-Azab MF; Saragovi HU; El-Remessy AB
Diabetologia; 2013 Oct; 56(10):2329-39. PubMed ID: 23918145
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas.
Zhang X; Bao S; Lai D; Rapkins RW; Gillies MC
Diabetes; 2008 Apr; 57(4):1026-33. PubMed ID: 18174522
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway.
Elshaer SL; Alwhaibi A; Mohamed R; Lemtalsi T; Coucha M; Longo FM; El-Remessy AB
Diabetologia; 2019 Aug; 62(8):1488-1500. PubMed ID: 31073629
[TBL] [Abstract][Full Text] [Related]
12. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
[TBL] [Abstract][Full Text] [Related]
13. Protective Effects of Leukemia Inhibitory Factor on Retinal Vasculature and Cells in Streptozotocin-induced Diabetic Mice.
Yang XF; Huang YX; Lan M; Zhang TR; Zhou J
Chin Med J (Engl); 2018 Jan; 131(1):75-81. PubMed ID: 29271384
[TBL] [Abstract][Full Text] [Related]
14. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
[TBL] [Abstract][Full Text] [Related]
15. Cross-Talk between Sirtuin 1 and the Proinflammatory Mediator High-Mobility Group Box-1 in the Regulation of Blood-Retinal Barrier Breakdown in Diabetic Retinopathy.
Mohammad G; Abdelaziz GM; Siddiquei MM; Ahmad A; De Hertogh G; Abu El-Asrar AM
Curr Eye Res; 2019 Oct; 44(10):1133-1143. PubMed ID: 31136205
[No Abstract] [Full Text] [Related]
16. Ursodeoxycholic acid ameliorates diabetic retinopathy via reducing retinal inflammation and reversing the breakdown of blood-retinal barrier.
Ouyang H; Mei X; Zhang T; Lu B; Ji L
Eur J Pharmacol; 2018 Dec; 840():20-27. PubMed ID: 30268667
[TBL] [Abstract][Full Text] [Related]
17. Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats.
Desjardins DM; Yates PW; Dahrouj M; Liu Y; Crosson CE; Ablonczy Z
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2706-13. PubMed ID: 27191823
[TBL] [Abstract][Full Text] [Related]
18. Significance of outer blood-retina barrier breakdown in diabetes and ischemia.
Xu HZ; Le YZ
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2160-4. PubMed ID: 21178141
[TBL] [Abstract][Full Text] [Related]
19. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.
Kim D; Mecham RP; Nguyen NH; Roy S
Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398
[TBL] [Abstract][Full Text] [Related]
20. Retinal thickness and subnormal retinal oxygenation response in experimental diabetic retinopathy.
Luan H; Roberts R; Sniegowski M; Goebel DJ; Berkowitz BA
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):320-8. PubMed ID: 16384980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
